Exacerbations, Health Resource Utilization, and Costs Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease Treated with Nebulized Arformoterol Following a Respiratory Event

Background: Long-acting beta2-agonists (LABAs), with or without inhaled corticosteroids (ICSs), delivered by handheld inhalers or nebulizers are recommended as maintenance therapy in chronic obstructive pulmonary disease (COPD). This study evaluated exacerbations, health resource utilization (HRU),...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Chronic Obstr Pulm Dis
Autori principali: Navaie, Maryam, Celli, Bartolome R., Xu, Zhun, Cho-Reyes, Soojin, Dembek, Carole, Gilmer, Todd P.
Natura: Artigo
Lingua:Inglês
Pubblicazione: COPD Foundation Inc 2019
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7006702/
https://ncbi.nlm.nih.gov/pubmed/31483988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15326/jcopdf.6.4.2019.0127
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi